Oak Thistle LLC Cuts Stock Holdings in Teleflex Incorporated $TFX

Oak Thistle LLC trimmed its position in shares of Teleflex Incorporated (NYSE:TFX) by 75.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,195 shares of the medical technology company’s stock after selling 25,682 shares during the quarter. Oak Thistle LLC’s holdings in Teleflex were worth $1,003,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Cetera Investment Advisers purchased a new position in Teleflex during the first quarter worth about $206,000. Nuveen LLC purchased a new stake in Teleflex in the 1st quarter valued at about $15,914,000. HighTower Advisors LLC lifted its position in shares of Teleflex by 2.7% during the 1st quarter. HighTower Advisors LLC now owns 5,102 shares of the medical technology company’s stock worth $705,000 after buying an additional 133 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Teleflex by 69.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock worth $119,927,000 after buying an additional 355,720 shares during the last quarter. Finally, Raymond James Financial Inc. grew its holdings in shares of Teleflex by 1.2% in the first quarter. Raymond James Financial Inc. now owns 58,795 shares of the medical technology company’s stock valued at $8,125,000 after acquiring an additional 686 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

NYSE TFX opened at $124.50 on Friday. The firm has a market cap of $5.50 billion, a P/E ratio of -16.94, a price-to-earnings-growth ratio of 1.49 and a beta of 0.95. The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. The company’s 50 day moving average is $120.09 and its 200-day moving average is $121.02. Teleflex Incorporated has a 12-month low of $102.58 and a 12-month high of $185.94.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business had revenue of $892.90 million during the quarter, compared to analyst estimates of $892.79 million. During the same period in the previous year, the business earned $3.49 EPS. Teleflex’s revenue was up 19.4% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Friday, November 14th. Teleflex’s payout ratio is presently -18.50%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on TFX shares. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a report on Monday. Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Tuesday, December 9th. Zacks Research downgraded shares of Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $135.00 price objective on shares of Teleflex in a research report on Wednesday. One analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $142.43.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.